Externally applied drug for curing thromboangiitis obliterans

A technology for external use of drugs and thrombus occlusion, which can be used in drug combinations, cardiovascular system diseases, medical preparations containing active ingredients, etc., can solve problems such as unsatisfactory curative effects, and achieve obvious effects

Active Publication Date: 2013-01-16
杨剑礼
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The object of the present invention is to provide a kind of external medicine for treating thromboangiitis obliterans in order to solve the problem of unsatisfactory curative effect of the external medicine for treating thromboangiitis obliterans

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Xiao, male, 43 years old, farmer, came to the clinic on September 20, 2000. He complained of heavy cold pain in his right lower limb for 5 years, which had been aggravated for half a year. The patient had cold pain in his lower limb caused by wading 5 years ago. Aggravated, the right leg was cold, the pain was extremely unbearable, and he could not sleep at night. He was diagnosed as thromboangiitis obliterans by a certain hospital, and the effect of multiple treatments was not good. The hospital suggested amputation for treatment, but the patient did not agree, so he came for treatment. Check: the right foot is bruised and purple, the great toe of the right foot has collapsed, and the bones can be seen. The Yang pulse is slight, the tongue is blue and purple, the fur is white and moist, and the pulse is deep and slow. Blood wrap method treatment, the prescription is composed of: 30 grams of Tuyuan, 15 grams of Guizhi, 30 grams of papaya, 30 grams of Rehmannia glutinosa,...

Embodiment 2

[0018] Li, male, 53 years old, a farmer, was diagnosed with thromboangiitis obliterans by a certain hospital, and the treatment effect in many places was not good. The six-flavored medicinal stone mortar of the present invention was smashed to fine powder, mixed with fresh chicken blood, and mixed well Spread it on a white cloth with a width of 10-20cm and a length of 80-100cm, and wrap it up from the affected part for 24 hours. After wrapping it off, there will be itchy blisters. Use 0.9%-2.0% saline for washing. If the blisters break, rub purple lotion on the outside, and use it for eight weeks. recovered.

Embodiment 3

[0020] Sun Mou, male, 46 years old, farmer, was diagnosed as thromboangiitis obliterans by a certain hospital, and the effect of seeking treatment in many places was not good. The hospital suggested amputation for treatment, but the patient did not agree, so he came for treatment. With medicine of the present invention recover from illness after three months.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an externally applied drug for curing thromboangiitis obliterans. The externally applied drug is characterized in that the externally applied drug comprises 200 ml of fresh local chicken blood, 30 g of dried body of ground beetle, 15 g of cassia twig, 30g of Chinese flowering quince, 30 g of prepared rehmannia root, 30 g of figwort root and 40 g of seeds of potherb mustard; and the accuracy degree of dose of the prescription is plus or minus 10 percent of each drug. The externally applied drug has obvious effect for curing thromboangiitis obliterans including intermittent claudication, rest pain and migrating thrombophlebitis, is safe and effective, and does not has any side effects.

Description

technical field [0001] The invention mainly relates to a medicine for external use for treating thromboangiitis obliterans, and belongs to the field of medicine manufacture for external use. Background technique [0002] Thromboangiitis obliterans mainly invades the limbs, especially the small and medium arteries of the lower limbs and their accompanying veins and superficial skin veins. The affected blood vessels present non-suppurative inflammation of the whole thickness of the vessel wall, and there is thrombosis in the lumen. The lumen presents progressive stenosis or even complete occlusion, causing limb ischemia and pain. In severe cases, ulcers and gangrene that are not easy to heal may occur in the extremities. The etiology is still unclear. Permanent disability or loss of a limb, or even death, may result. Tuyuan, papaya, and cassia twig can promote blood circulation and remove blood stasis, dispel dampness and warm meridians, relax tendons and activate collat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/808A61P9/14A61K35/64A61K35/14A61K35/57
Inventor 杨剑礼
Owner 杨剑礼
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap